|
|
||||||||
mediates leptin induction during inflammation
1 Metabolism Section, Veterans Affairs Medical Center, University of California, San Francisco, California 94121; and 2 Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, Colorado 80262
| |
ABSTRACT |
|---|
|
|
|---|
Interleukins
(IL) are key mediators of the host response to infection and
inflammation. Leptin is secreted by adipose tissue and plays an
important role in the control of food intake. Administration of
lipopolysaccharide (LPS), tumor necrosis factor (TNF), or IL-1 acutely
increases leptin mRNA and protein levels. To investigate the role of
IL-1
and IL-6 in leptin expression during inflammation, we used
IL-1
-deficient (
/
) and IL-6
/
mice. Mice
were injected intraperitoneally with LPS or subcutaneously with
turpentine, as models of systemic or local inflammation, respectively.
In IL-1
+/+ mice, both LPS and turpentine increased leptin mRNA and
circulating leptin. In contrast, neither LPS nor turpentine increased
leptin levels in IL-1
/
mice. In IL-6 +/+ or IL-6
/
mice, turpentine increased leptin protein to comparable
levels. We conclude that IL-1
is essential for leptin induction by
both LPS and turpentine in mice, but IL-6 is not.
Ob protein; interleukin-6; interleukin-1
; turpentine; endotoxin; lipopolysaccharide; knockout mice
| |
INTRODUCTION |
|---|
|
|
|---|
INTERLEUKIN (IL)-1 is one of the key mediators of the host response to tissue injury, infection, or inflammation. Administration of IL-1 itself or of inducers of IL-1, such as lipopolysaccharide (LPS) or turpentine, mimics many of the pathophysiological changes that occur during infection or inflammation, such as anorexia, fever, induction of acute phase proteins, hypoglycemia, and activation of the hypothalamic-pituitary-adrenal (HPA) axis (8, 26).
The biological activity of IL-1 is mediated by two different gene
products, IL-1
and IL-1
, which share similar biological activities by binding to the same receptors. IL-1
remains mostly membrane associated or within cells, whereas IL-1
is usually secreted (8). With the use of IL-1
-deficient (IL-1
/
) mice, IL-1
has been shown to be an essential
mediator of the inflammatory, pyrogenic, and anorectic response
elicited by the local tissue damage caused by subcutaneous injection of
turpentine (33). Studies with antibodies to IL-1
have also shown
that IL-1
contributes to LPS-induced fever (20). However, the
generation of the inflammatory responses to LPS, such as anorexia,
activation of HPA axis, increases in IL-1
, tumor necrosis factor
(TNF)-
, and IL-6, and the induction of acute phase proteins, are
observed even in absence of IL-1
expression (12).
IL-6 is another mediator of the host response to inflammation. IL-6
/
mice do not develop an acute phase response (APR) or
anorexia in response to turpentine (13). Moreover, IL-6 has been shown
to be the primary mediator of the fever induced by either LPS or
IL-1
(3). However, IL-6
/
mice exhibit anorexia, hypoglycemia, induction of acute phase proteins, and activation of the
HPA axis after LPS administration (13). In the inflammatory response
induced by LPS, multiple cytokines with overlapping activities, including IL-1
, IL-1
, TNF-
and IL-6, are simultaneously
induced, whereas turpentine specifically induces only IL-1
and IL-6
without any detectable increase in TNF-
or IL-1
(10, 11).
Therefore, multiple cytokines contribute to the development of the APR
elicited by LPS, but it appears that only IL-1
and IL-6 regulate the
inflammatory response to turpentine.
Leptin (Ob protein), the product of the ob gene, is a 16-kDa protein synthesized by adipose tissue that plays a crucial role in the homeostasis of body weight by regulating food intake and energy expenditure (32). Administration of leptin to rodents decreases food intake and body weight and increases energy consumption (25). Fasting and starvation decrease leptin mRNA and protein levels, and this substantial fall represents a signal to eat (6, 22). Defects in leptin or leptin receptor gene expression cause severe obesity in rodents (4, 31).
We have shown that administration of LPS, IL-1, or TNF-
acutely
increases steady-state levels of the mRNA for leptin in adipose tissue
and circulating levels of leptin in hamsters (17). In addition, Sarraf
and colleagues (28) have demonstrated that LPS and proinflammatory
cytokines induce leptin expression in mice. These data suggest that
leptin induction during inflammation is regulated in a manner similar
to the cytokine response to infection and injury. The observation that
the leptin receptor is homologous to the gp130 family, the
signal-transducing subunit of the IL-6-type cytokine receptors (4),
further supports the hypothesis that leptin might play a role in the
inflammatory response. Moreover, recent work showed that leptin
stimulates the immune system, because leptin enhances cytokine
production and phagocytosis by macrophages (16). A direct effect of
leptin on development and differentation of hemopoietic lineages has
also been described (23).
To further clarify the regulation of leptin induction during the host
response to infection and inflammation, we determined whether other
stimuli, such as local sterile tissue damage induced by the
subcutaneous injection of turpentine, can induce leptin mRNA expression
and leptin synthesis in mice. In addition, using IL-1
/
and IL-6
/
mice, we determined the
specific role played by these cytokines in leptin induction after
turpentine and LPS administration.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials. [32P]dCTP (3,000 Ci/mmol) was purchased from NEN (Boston, MA), LPS (a phenol-extracted preparation from E. coli serotype O55:B5) was from Sigma (St. Louis, MO), multiprime DNA labeling system kits were purchased from Amersham Life Sciences International (Arlington Heights, IL), Minispin Sephadex G-50 columns were from Worthington Biochemical (Freehold, NJ), and Nytran+ nylon membranes were from Schleicher and Schuell (Keene, NH).
Animals and treatments.
IL-1
/
mice were generated as previously described
(33). IL-6
/
mice were purchased from Jackson Laboratory,
Bar Harbor, ME. Four- to six-week-old male IL-1
+/+ and IL-1
/
or IL-6 +/+ and IL-6
/
mice of mixed
C57BL/6 and 129/Sv background, housed five per cage, were used. LPS was
administered intraperitoneally at a dose of 5 mg/kg, a dose of LPS that
has been previously shown to induce APR in mice (12). Steam-distilled
turpentine was injected subcutaneously at a dose of 100 µl in the
hindlimb. Control mice were injected intraperitoneally or
subcutaneously with sterile, pyrogen-free saline. All animal protocols
were approved by the Animal Studies Committee of the San Francisco
Veterans Affairs Medical Center.
Isolation of RNA and Northern blotting. Total RNA was isolated from epididymal adipose tissue by modification of the method of Chomczynsky and Sacchi (5). Fat tissue obtained from each mouse was individually processed. Lipid extraction with CHCl3 was performed immediately after homogenization; the aqueous phase was then acidified and subjected to the standard acid-phenol-chloroform extraction. Gel electrophoresis, transfer, Northern blotting, and densitometry were performed as previously described (14). A murine ob gene cDNA probe, generated as previously described (17), was used. Because we and others have shown that LPS and cytokines increase mRNA levels of "housekeeping" genes such as actin and cyclophilin, two mRNAs commonly used for normalizing data, we loaded equal amounts of total RNA (10 µg, determined by spectrophotometry) and assessed uniformity of sample application by ultraviolet visualization of the acridine orange-stained ribosomal RNAs in the gel before electrophoretic transfer. We have previously reported that the effects of LPS or cytokines are specific for individual mRNAs in individual tissues both in terms of increased or decreased levels and of the order of magnitude of the change. For example, treatment of hamsters with LPS or cytokines decreases the level of cholesterol ester transfer protein mRNA in adipose tissue (18). In liver, specific mRNAs may be either increased or decreased to varying degrees ranging from 30-fold increases to 95% decreases (14, 15).
Leptin and IL-6 measurement. Serum leptin levels were measured using a radioimmunoassay kit specific for mouse leptin (Linco Research, St. Charles, MO). Serum IL-6 levels were measured using a mouse enzyme-linked immunosorbent assay kit, kindly provided by Endogen (Cambridge, MA).
Statistical analysis. Analysis of variance with post hoc Bonferroni's test was used. Data are expressed as means ± SE.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
To explore whether inflammatory stimuli other than LPS were able to
induce leptin, we tested the effect of subcutaneous turpentine (100 µl) on leptin levels in IL-1
+/+ and IL-1
/
mice.
Control mice received subcutaneous saline. As shown in Fig.
1, A and
B, high levels of leptin in serum and
leptin mRNA in adipose tissue were detected in fed IL-1
+/+ and
IL-1
/
mice compared with fasted mice. However,
despite fasting, which normally suppresses leptin expression (1),
turpentine markedly induced leptin synthesis and mRNA levels 16 h after
treatment in IL-1
+/+ mice. Time course experiments demonstrated
that 16 h was the time of maximal induction of leptin (data not shown).
In contrast, in IL-1
/
mice, the induction of leptin
gene expression and synthesis after turpentine was dramatically
impaired, demonstrating that IL-1
is essential for
turpentine-induced leptin.
|
To elucidate the role of IL-1
in leptin production in another model
of inflammation, IL-1
+/+ and IL-1
/
mice were
challenged with LPS (5 mg/kg ip) and then fasted. Control fasted mice
were injected intraperitoneally with saline. Despite fasting, which under physiological conditions is accompanied by low levels of leptin,
leptin protein (Fig.
2A) and
mRNA levels (Fig. 2B) were markedly
increased 6 h after LPS treatment in IL-1
+/+ mice. Time course
experiments showed that LPS induced maximal expression of leptin at 6 h
(data not shown). When LPS was injected in IL-1
/
mice, however, leptin synthesis and mRNA levels did not increase over
basal levels, demonstrating that IL-1
also mediates the leptin
response to LPS, a model of systemic inflammation.
|
The requirement for IL-1
in the induction of leptin during
turpentine-induced inflammation is consistent with the essential role
played by IL-1
in turpentine-induced APR (33). However, the result
that IL-1
was also essential for LPS induction of leptin was
unexpected. After turpentine, IL-1
and IL-6 are the sole detectable cytokines, and they are required for the development of
the systemic APR. In fact, no APR is observed after turpentine in
either IL-1
/
or IL-6
/
mice (13, 33).
In contrast, the systemic response to LPS is characterized by the
induction of several cytokines, such as TNF, IL-1
, and IL-6 (10).
These cytokines have pleiotropic and redundant activities and exhibit a
pattern of mutual induction, modulating each other's production. Moreover, each of these cytokines is independently induced by LPS;
therefore no single cytokine is considered crucial for most LPS-induced
responses. However, despite the redundancy that characterizes many of
the responses to LPS, the induction of leptin after LPS appears to be
completely under the control of IL-1
.
As shown in Table 1, both LPS and
turpentine increased serum IL-6 in IL-1
+/+ mice. IL-6 serum levels
were measured at the time of maximal induction for each agent, 3 h for
LPS and 16 h for turpentine. As previously shown (12, 33), the
induction of IL-6 after LPS administration was only slightly reduced in IL-1
/
mice, whereas turpentine did not induce IL-6 in
IL-1
/
mice. Therefore, either LPS directly induces
IL-6, or other cytokines with overlapping activities appear to
compensate for the absence of IL-1
for the production of IL-6 after
LPS. In contrast, IL-1
is essential for IL-6 production during
turpentine-induced inflammation, suggesting a cascade in which
turpentine first induces IL-1
, which in turn induces IL-6. Moreover,
IL-6
/
mice do not develop an APR in response to
turpentine (13, 19). Therefore, the impaired inflammatory response to
turpentine observed in IL-1
/
mice appears to be a
consequence of the absence of the induction of IL-6, which mediates the
APR initiated by turpentine.
|
To evaluate the role of IL-6 in IL-1
-mediated induction of leptin
after turpentine, we studied the reponse of IL-6
/
mice. As shown in Fig. 3, no differences were
observed between IL-6 +/+ and IL-6
/
mice in circulating
levels of leptin 16 h after turpentine. The equivalent response induced
in both groups of mice indicates that leptin induction by turpentine
occurs even in the absence of IL-6, demonstrating that IL-1
independently induces both IL-6 and leptin (Fig.
4).
|
|
The increase in leptin after either turpentine or LPS indicates
that leptin is part of the host's cytokine response to inflammation. Leptin regulates feeding behavior and therefore may be a mediator of
the anorexia associated with chronic and acute inflammation. However,
we have shown that ob/ob and
db/db mice, which are defective in
leptin and leptin receptor, respectively, are responsive to LPS in
terms of anorexia (9), suggesting that leptin is not the sole cause of
the anorexia induced by LPS. These results are in agreement with the
finding that LPS induces anorexia even in absence of IL-1
and
therefore in the absence of induction of leptin (12).
The primary role of IL-1
in the induction of leptin during
inflammation suggests that some of the biological activities of IL-1
itself may be specifically mediated by leptin. IL-1
is anorexigenic,
and leptin might contribute to IL-1
-induced anorexia (30). However,
it has been shown that central administration of IL-1
induced
greater anorexia in fa/fa rats, which
have a mutation in the leptin receptor and display the same phenotype as the db/db mice, than in lean rats
(27). Thus centrally injected IL-1
might induce anorexia through a
different pathway than when injected or produced in the periphery. A
selective subdiaphragmatic vagal deafferentation does not block
anorexia induced by peripheral LPS or IL-1
(29), supporting the
concept that different mechanisms are involved in the anorexia induced
by central or peripheral stimuli. It is therefore possible that
IL-1
-induced leptin in the periphery could be part of the mechanism
of the anorexia induced by peripherally injected IL-1
.
Leptin regulates energy balance not only by decreasing food intake, but
also by increasing energy expenditure via activation of the sympathetic
nervous system (25). The pyrogenic and thermogenic response to IL-1
is impaired in fa/fa rats (7).
Therefore, leptin may contribute to thermogenesis during inflammation
by mediating the increase in brown adipose tissue sympathetic and thermogenic activity induced by IL-1
.
On the other hand, in addition to regulating food intake and energy expenditure, leptin may have other physiological functions. Constitutive levels of mRNA for leptin receptor are present not only in the hypothalamus, but also in regions of the brain not directly involved in the regulation of food intake. Moreover, ob/ob and db/db mice are not only obese but also have a variety of hormonal and metabolic disorders, including infertility and a dysfunctional adrenal and thyroid axis. Several reports showed an important role for leptin in reproductive physiology (2). Alterations in thyroid, adrenal, and reproductive functions occur during infection and inflammation, and it is possible that leptin mediates or modulates, at least in part, these neuroendocrine responses.
In addition, a short isoform of leptin receptor mRNA is expressed in many peripheral tissues and cells, including kidney, lung, liver, spleen, and macrophages (23, 31) and recently has been shown to be capable of transmitting signals (24). Moreover, leptin has been shown to enhance cytokine production and phagocytosis by macrophages and stimulates hematopoiesis (16, 23). This potential role in the hemopoietic and immune system development might also explain the impairments seen in the immune system of ob/ob mice.
In summary, our data show that leptin is induced after injection of
turpentine or LPS and that IL-1
has an essential role in the
induction of leptin during local and systemic inflammation.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Hui Zheng at Merck Research Laboratories for kindly
providing us with the IL-1
/
mice.
| |
FOOTNOTES |
|---|
This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (DK-40990 and DK-49448), National Institute of Allergy and Infectious Diseases (AI-15614), Research Service of the Department of Veterans Affairs, and University of California, San Francisco AIDS Clinical Research Center (CC98-5F-139).
R. Faggioni and G. Fantuzzi contributed equally to this paper.
Address for reprint requests: C. Grunfeld, Metabolism Section (111F), Dept. of Veterans Affairs Medical Center, 4150 Clement St., San Francisco, CA 94121.
Received 19 August 1997; accepted in final form 3 October 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ahima, R. S.,
D. Prabakaran,
C. Mantzoros,
D. Qu,
B. Lowell,
E. Maratos-Flier,
and
J. S. Flier.
Role of leptin in the neuroendocrine response to fasting.
Nature
382:
250-252,
1996[Medline].
2.
Barash, I. A.,
C. C. Cheung,
D. S. Weigle,
H. Ren,
E. B. Kabisting,
J. L. Kuijper,
D. K. Clifton,
and
R. A. Steiner.
Leptin is a metabolic signal to the reproductive system.
Endocrinology
137:
3144-3147,
1996[Abstract].
3.
Chai, Z.,
S. Gatti,
C. Toniatti,
V. Poli,
and
T. Bartfai.
Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipolysaccharide or IL-1
: a study on IL-6-deficient mice.
J. Exp. Med.
183:
311-316,
1996
4.
Chen, H.,
O. Charlat,
L. A. Tartaglia,
E. A. Woolf,
X. Weng,
S. J. Ellis,
N. D. Lakey,
J. Culpepper,
K. J. Moore,
R. E. Breitbart,
G. M. Duyk,
R. I. Tepper,
and
J. P. Morgenstern.
Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice.
Cell
84:
491-495,
1996[Medline].
5.
Chomczynski, P.,
and
N. Sacchi.
Single step method of RNA isolation by acid guanidium tiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:
150-159,
1987[Medline].
6.
Considine, R. V.,
M. K. Sinha,
M. L. Heiman,
A. Kriauciunas,
T. W. Stephens,
M. R. Nyce,
J. P. Ohannesian,
C. C. Marco,
L. J. McKee,
T. L. Bauer,
and
J. F. Caro.
Serum immunoreactive-leptin concentrations in normal-weight and obese humans.
N. Engl. J. Med.
334:
292-325,
1996
7.
Dascombe, M. J.,
A. Hardwick,
R. A. Lefeuvre,
and
N. J. Rothwell.
Impaired effects of interleukin-1
on fever and thermogenesis in genetically obese rats.
Int. J. Obes.
13:
367-373,
1989[Medline].
8.
Dinarello, C. A.
Biological basis for interleukin-1 in disease.
Blood
87:
2095-2147,
1996
9.
Faggioni, R.,
J. Fuller,
A. Moser,
K. R. Feingold,
and
C. Grunfeld.
LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice.
Am. J. Physiol.
273 (Regulatory Integrative Comp. Physiol. 42):
R181-R186,
1997
10.
Fantuzzi, G.,
and
C. A. Dinarello.
The inflammatory response in interleukin-1
-deficient mice: comparison with other cytokine-related knock-out mice.
J. Leukoc. Biol.
59:
489-493,
1996[Abstract].
11.
Fantuzzi, G.,
G. Ku,
M. W. Harding,
D. J. Livingston,
K. Kuida,
R. A. Flavell,
and
C. A. Dinarello.
Response to local inflammation of IL-1
converting enzyme-deficient mice.
J. Immunol.
158:
1818-1824,
1997[Abstract].
12.
Fantuzzi, G.,
H. Zheng,
R. Faggioni,
F. Benigni,
P. Ghezzi,
J. D. Sipe,
A. R. Shaw,
and
C. A. Dinarello.
Effect of endotoxin in interleukin-1
-deficient mice.
J. Immunol.
157:
291-296,
1996[Abstract].
13.
Fattori, E.,
M. Cappelletti,
P. Costa,
C. Sellitto,
L. Cantoni,
M. Carelli,
R. Faggioni,
G. Fantuzzi,
P. Ghezzi,
and
V. Poli.
Defective inflammatory response in interleukin-6 deficient mice.
J. Exp. Med.
180:
1243-1250,
1994
14.
Feingold, K. R.,
A. L. Pollock,
A. H. Moser,
J. K. Shigenaga,
and
C. Grunfeld.
Effect of endotoxin on cholesterol metabolism during the acute phase response.
J. Lipid Res.
34:
2147-2158,
1993[Abstract].
15.
Feingold, K. R.,
A. L. Pollock,
A. H. Moser,
J. K. Shigenaga,
and
C. Grunfeld.
Discordant regulation of proteins of cholesterol metabolism during the acute phase response.
J. Lipid Res.
36:
1474-1482,
1995[Abstract].
16.
Gainsford, T.,
T. A. Willson,
D. Metcalf,
E. Handman,
C. McFarlane,
A. Ng,
N. A. Nicola,
W. S. Alexander,
and
D. J. Hilton.
Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.
Proc. Natl. Acad. Sci. USA
93:
14564-14568,
1996
17.
Grunfeld, C.,
C. Zhao,
J. Fuller,
A. Pollock,
A. Moser,
J. Friedman,
and
K. R. Feingold.
Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. A role for leptin in the anorexia of infection.
J. Clin. Invest.
97:
2152-2157,
1996[Medline].
18.
Hardardottir, I.,
A. H. Moser,
J. Juller,
C. Fielding,
K. R. Feingold,
and
C. Grunfeld.
Endotoxin and cytokines decrease serum levels of cholesteryl ester transfer protein and mRNA levels in Syrian hamsters.
J. Clin. Invest.
97:
2152-2157,
1996.
19.
Kopf, M.,
H. Baumann,
G. Freer,
M. Freudenberg,
M. Lamers,
T. Kishimoto,
R. Zinkernagel,
H. Bluethmann,
and
G. Kohler.
Impaired immune and acute-phase responses in interleukin-6-deficient mice.
Nature
368:
339-342,
1994[Medline].
20.
Long, N. C.,
I. Otterness,
S. L. Kunkel,
A. J. Vander,
and
M. J. Kluger.
Role of interleukin 1
and tumor necrosis factor in lipopolysaccharide fever in rats.
Am. J. Physiol.
259 (Regulatory Integrative Comp. Physiol. 28):
R724-R728,
1990
21.
Ly, H.,
O. L. Francone,
C. J. Fielding,
J. K. Shigenaga,
A. H. Moser,
C. Grunfeld,
and
K. R. Feingold.
Endotoxin and TNF lead to reduced plasma LCAT activity and decreased LCAT mRNA levels in Syrian hamsters.
J. Lipid Res.
36:
1254-1263,
1995[Abstract].
22.
Maffei, M.,
J. Halaas,
E. Ravussin,
R. E. Pratley,
G. H. Lee,
Y. Zhang,
H. Fei,
R. Kim,
R. Lallone,
S. Ranganathan,
P. A. Kern,
and
J. M. Friedman.
Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects.
Nat. Med.
1:
1155-1161,
1995[Medline].
23.
Mikhail, A. A.,
E. X. Beck,
A. Shafer,
B. Barut,
J. S. Gbur,
T. J. Zupancic,
A. C. Schweitzer,
J. A. Cioffi,
G. Lacaud,
B. Ouyang,
G. Keller,
and
H. R. Snodgrass.
Leptin stimulates fetal and adult erythroid and myeloid development.
Blood
5:
1507-1512,
1997.
24.
Murakami, T.,
T. Yamashita,
M. Iida,
M. Kuwajiama,
and
K. Shima.
A short form of leptin receptor performs signal transduction.
Biochem. Biophys. Res. Commun.
231:
26-29,
1997[Medline].
25.
Pelleymounter, M. A.,
M. J. Cullen,
M. B. Baker,
R. Hecht,
D. Winters,
T. Boone,
and
F. Collins.
Effects of the obese gene product on body weight regulation in ob/ob mice.
Science
269:
540-543,
1995
26.
Plata-Salaman, C. R.
Anorexia during acute and chronic disease.
Nutrition
12:
69-78,
1996[Medline].
27.
Plata-Salaman, C. R.,
J. R. Vaselli,
and
G. Sonti.
Differential responsiveness of obese (fa/fa) and lean (Fa/Fa) Zucker rats to cytokine-induced anorexia.
Obes. Res.
5:
36-42,
1997[Medline].
28.
Sarraf, P.,
R. C. Frederich,
E. M. Turner,
G. Ma,
N. T. Jaskowiak,
D. J. Rivet,
J. S. Flier,
B. B. Lowell,
D. L. Fraker,
and
H. R. Alexander.
Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia.
J. Exp. Med.
185:
171-175,
1997
29.
Schwartz, G. J.,
C. R. Plata-Salaman,
and
W. Langhans.
Subdiaphragmatic vagal deafferentation fails to block feeding-suppressive effects of LPS and IL-1
in rats.
Am. J. Physiol.
273 (Regulatory Integrative Comp. Physiol. 42):
R1193-R1198,
1997
30.
Sonti, G.,
S. E. Ilyin,
and
C. R. Plata-Salaman.
Anorexia induced by cytokine interactions at pathophysiological concentrations.
Am. J. Physiol.
270 (Regulatory Integrative Comp. Physiol. 39):
R1394-R1402,
1996
31.
Tartaglia, L. A.,
M. Dembski,
X. Weng,
N. Deng,
J. Culpepper,
R. Devos,
G. J. Richards,
L. A. Campfield,
F. T. Clark,
J. Deeds,
C. Muir,
S. Sanker,
A. Moriarty,
K. J. Moore,
J. S. Smutko,
G. G. Mays,
E. A. Woolf,
C. A. Monroe,
and
R. I. Tepper.
Identification and expression cloning of a leptin receptor, OB-R.
Cell
83:
1263-1271,
1995[Medline].
32.
Zhang, Y.,
R. Proenca,
M. Maffei,
M. Barone,
L. Leopold,
and
J. M. Friedman.
Positional cloning of the mouse obese gene and its human homologue.
Nature
372:
425-432,
1994[Medline].
33.
Zheng, H.,
D. Fletcher,
W. Kozak,
M. Jiang,
K. Hofmann,
C. A. Conn,
D. Soszynski,
C. Grabiec,
M. E. Trumbauer,
A. Shaw,
M. J. Kostura,
K. Stevens,
H. Rosen,
R. J. North,
H. Y. Chen,
M. J. Tocci,
M. J. Kluger,
and
L. H. T. Van der Ploeg.
Resistance to fever induction and impaired acute-phase response in interleukin-1
deficient mice.
Immunity
3:
9-19,
1995[Medline].
This article has been cited by other articles:
![]() |
G. N. Luheshi and C. Rummel Is programming of weight regulation immune to neonatal inflammation? Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R578 - R580. [Full Text] [PDF] |
||||
![]() |
Y. Abe, K. Ono, T. Kawamura, H. Wada, T. Kita, A. Shimatsu, and K. Hasegawa Leptin induces elongation of cardiac myocytes and causes eccentric left ventricular dilatation with compensation Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2387 - H2396. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Hick, A. L. Gruver, M. S. Ventevogel, B. F. Haynes, and G. D. Sempowski Leptin Selectively Augments Thymopoiesis in Leptin Deficiency and Lipopolysaccharide-Induced Thymic Atrophy J. Immunol., July 1, 2006; 177(1): 169 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wang, J. R. Jenkins, and P. Trayhurn Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-{alpha} Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E731 - E740. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-Y. Guo, P. Halo, R. L. Leibel, and Y. Zhang Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R112 - R119. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Madiehe, T. D. Mitchell, and R. B. S. Harris Hyperleptinemia and reduced TNF-alpha secretion cause resistance of db/db mice to endotoxin Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R763 - R770. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Finck and R. W. Johnson Anti-inflammatory agents inhibit the induction of leptin by tumor necrosis factor-alpha Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1429 - R1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Gaetke, H. S. Oz, W. J. S. de Villiers, G. W. Varilek, and R. C. Frederich The Leptin Defense against Wasting Is Abolished in the IL-2-Deficient Mouse Model of Inflammatory Bowel Disease J. Nutr., May 1, 2002; 132(5): 893 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Ivanov and A. A. Romanovsky Fever responses of Zucker rats with and without fatty mutation of the leptin receptor Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R311 - R316. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. FAGGIONI, K. R. FEINGOLD, and C. GRUNFELD Leptin regulation of the immune response and the immunodeficiency of malnutrition FASEB J, December 1, 2001; 15(14): 2565 - 2571. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Azuma, H Suto, Y Ito, M Ohtani, M Dojo, M Kuriyama, and T Kato Gastric leptin and Helicobacter pylori infection Gut, September 1, 2001; 49(3): 324 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dahlgren, C. Nilsson, E. Jennische, H.-P. Ho, E. Eriksson, A. Niklasson, P. Bjorntorp, K. A. Wikland, and A. Holmang Prenatal cytokine exposure results in obesity and gender-specific programming Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E326 - E334. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Arai, K. Kim, K. Kaneko, M. Iketani, A. Otagiri, N. Yamauchi, and T. Shibasaki Nicotine infusion alters leptin and uncoupling protein 1 mRNA expression in adipose tissues of rats Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E867 - E876. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fantuzzi and R. Faggioni Leptin in the regulation of immunity, inflammation, and hematopoiesis J. Leukoc. Biol., October 1, 2000; 68(4): 437 - 446. [Abstract] [Full Text] |
||||
![]() |
E. C. CREUTZBERG, E. F. M. WOUTERS, I. M. L. VANDERHOVEN-AUGUSTIN, M. A. DENTENER, and A. M. W. J. SCHOLS Disturbances in Leptin Metabolism Are Related to Energy Imbalance during Acute Exacerbations of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1239 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Faggioni, A. Moser, K. R. Feingold, and C. Grunfeld Reduced Leptin Levels in Starvation Increase Susceptibility to Endotoxic Shock Am. J. Pathol., May 1, 2000; 156(5): 1781 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Reznikov, B. D. Shames, H. A. Barton, C. H. Selzman, G. Fantuzzi, S.-H. Kim, S. M. Johnson, and C. A. Dinarello Interleukin-1beta deficiency results in reduced NF-kappa B levels in pregnant mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R263 - R270. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Luheshi, J. D. Gardner, D. A. Rushforth, A. S. Loudon, and N. J. Rothwell Leptin actions on food intake and body temperature are mediated by IL-1 PNAS, June 8, 1999; 96(12): 7047 - 7052. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kapur, B. Marcotte, and A. Marette Mechanism of adipose tissue iNOS induction in endotoxemia Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E635 - E641. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Carlson, M. Saeed, R. A. Little, and M. H. Irving Serum leptin concentrations and their relation to metabolic abnormalities in human sepsis Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E658 - E662. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Faggioni, G. Fantuzzi, C. Gabay, A. Moser, C. A. Dinarello, K. R. Feingold, and C. Grunfeld Leptin deficiency enhances sensitivity to endotoxin-induced lethality Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R136 - R142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Porter, B. J. Hrupka, W. Langhans, and G. J. Schwartz Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta , LPS, and MDP Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R384 - R389. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Faggioni, J. Jones-Carson, D. A. Reed, C. A. Dinarello, K. R. Feingold, C. Grunfeld, and G. Fantuzzi Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: Role of tumor necrosis factor alpha and IL-18 PNAS, February 29, 2000; 97(5): 2367 - 2372. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||